6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of July, 2022

(Commission File No. 001-41157)

 

BIONOMICS LIMITED

(Translation of registrant’s name into English)

 

200 Greenhill Road

Eastwood SA 5063

Tel: +618 8150 7400

(Address of registrant’s principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):

Yes ☐ No ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):

Yes ☐ No ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☐

 

 

 


 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

On July 04, 2022, the Company lodged a Notification of Cessation of Securities in relation to the expiry of unlisted options under an employee incentive plan on Appendix 3H with the ASX, as required by the laws and regulations of Australia, to disclose a change in interests in securities and contracts of the Company. The Notification of Cessation of Securities is furnished herewith as Exhibit 99.1 to this report on Form 6-K.

1


 

EXHIBIT INDEX

 

 

 

Exhibit

 

Description

 

99.1

Appendix 3H_Notification of Cessation of Securities

 

 

 

2


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

 

 

 

 

Bionomics Limited

 

(Registrant)

 

 

 

 

By:

/s/ Errol De Souza

 

 

Name:

Errol De Souza, Ph.D.

 

Title:

Executive Chairman

Date: July 05, 2022

 

1


EX-99.1

 

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_0.jpg 

Notification of cessation of +securities

 

Announcement Summary

Entity name

BIONOMICS LIMITED

Announcement Type
New announcement

Date of this announcement
Monday July 04, 2022

Details of +securities that have ceased

 

Number of

ASX +security +securities that The +securities have Date of

code Security description have ceased ceased due to cessation

BNOAO OPTION EXPIRING 386,600 Expiry of option or other 12/06/2022

VARIOUS DATES EX convertible security without

VARIOUS PRICES exercise or conversion

Refer to next page for full details of the announcement

 

 


Exhibit 99.1

 

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_1.jpg 

Notification of cessation of +securities

 

Part 1 - Announcement Details

1.1 Name of +Entity
BIONOMICS LIMITED

We (the entity named above) provide the following information about our issued capital.

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_2.jpg 

1.2 Registered Number Type ABN

1.3 ASX issuer code BNO

1.4 The announcement is

New announcement

Registration Number

53075582740

1.5 Date of this announcement 4/7/2022

Notification of cessation of +securities 2 / 4

 

 


Exhibit 99.1

 

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_3.jpg 

Notification of cessation of +securities

 

Part 2 - Details of +equity securities or +debt securities that have ceased

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_4.jpg 

ASX +Security Code and Description

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

Unquoted +equity securities that have ceased

Number of securities that have ceased
386,600

Reason for cessation

Expiry of option or other convertible security without exercise or conversion

 

Date of cessation

12/6/2022

Is the entity paying any consideration for the cessation?

No

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_5.jpg 

 

Any other information the entity wishes to notify to ASX about the cessation?

Notification of cessation of +securities 3 / 4

 

 


Exhibit 99.1

https://cdn.kscope.io/13837bda73488956f00044af7a393f88-img65882896_6.jpg 

Notification of cessation of +securities

 

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

Total number of ASX +security code and description +securities on issue

BNO : ORDINARY FULLY PAID 1,353,350,744

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

Total number of ASX +security code and description +securities on issue

BNOAO : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 79,056,617

BNOAS : WARRANTS 142,000,000

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities 4 / 4